Six-year absolute invasive disease-free survival benefit of adding adjuvant pertuzumab to trastuzumab and chemotherapy for patients with early HER2-positive breast cancer: A Subpopulation Treatment Effect Pattern Plot (STEPP) analysis of the APHINITY (BIG 4-11) trial

Publication | Open Access

DOI Full Paper Access

Citations

References

2022

Year

Richard D. Gelber, Xin V. Wang, Bernard F. Cole, David Cameron, Fátima Cardoso, Vivianne C. G. Tjan‐Heijnen, Ian E. Krop, Sherene Loi, Roberto Salgado, Astrid Kiermaier,

European Journal of Cancer

Abstract

References